Drug Type Small molecule drug |
Synonyms ABLi 04BP, ABLi04BP |
Target |
Action inhibitors |
Mechanism ABL1 inhibitors(ABL proto-oncogene 1 inhibitors) |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Lewy Body Disease | Preclinical | United States | 01 Jun 2025 | |
Multiple System Atrophy | Preclinical | United States | 01 Jun 2025 | |
Parkinson Disease | Preclinical | United States | 01 Jun 2025 |